Barbara Hobo

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “CERTL Reduces C16 Ceramide, Amyloid-β Levels and Inflammation in a Model of Alzheimer's Disease”.

CERTL Reduces C16 Ceramide, Amyloid-β Levels and Inflammation in a Model of Alzheimer's Disease

Research Square(2020)10.21203/rs.3.rs-42740/v1

N/A

0DataRank · unranked

0 citations

Qian Luo, Jo Stevens, Caterina Giovagnoni, Daan van Kruining, Gerard H. Bode +17 more

CERTL reduces C16 ceramide, amyloid-β levels and inflammation in a model of Alzheimer's disease

Research Square(2020)10.21203/rs.3.rs-42740/v2

N/A

0DataRank · unranked

0 citations

Qian Luo, Jo Stevens, Caterina Giovagnoni, Daan van Kruining, Gerard H. Bode +18 more

CERTL reduces C16 ceramide, amyloid-β levels, and inflammation in a model of Alzheimer’s disease

Alzheimer s Research & Therapy(2021)10.1186/s13195-021-00780-0

N/A

0DataRank · unranked

45 citations

Qian Luo, Jo Stevens, Caterina Giovagnoni, Daan van Kruining, Gerard H. Bode +18 more

CERTL reduces C16 ceramide, amyloid-β levels and inflammation in a model of Alzheimer's disease

Research Square(2021)10.21203/rs.3.rs-42740/v3

N/A

0DataRank · unranked

0 citations

Qian Luo, Jo Stevens, Caterina Giovagnoni, Daan van Kruining, Gerard H. Bode +18 more